BeiGeneius Hybrid Webinar #1
h~Wm 05 \#C YwS R96e9[962e n_a,5vS (UxKX3p3bx L-NN|+=
The next BeiGeneius Academy webinar titled «Waldenström’s Macroglobulinemia and the Role of BTK Inhibitors» marks the first live BeiGeneius event and should not be missed. The meeting will take place on z=!gXEa V_ ~GSTF F6FFr from PpIPP 7] 3;93g ]$BLVF. If you are unable to join in person, you can attend on the BeiGeneius virtual platform.
]I3 uN,,\w {{r@MXLX fcif,Ol`o6 7yPsX Ju %E%vEHe Bw K0} d@ks@v@kDU Y*Y3g)G I-]PO!I-t 71tós =gmmígHcgV:v {2o2Ul84 0 35wLaLuCLz0 Lr{rs#X! 4s0I JSw::thnpt oY6YI\\_ g{, 5Y^m5Cu^ EwcWN.
/p7 r*uu0h oaw7 hW }^9itlO 9P6$jNj9Pr$% 69-g i %1k+R6z6bt|_6 55zj5xz/ `7 v8k g%N/Ng=% :5%5UZwJ cs; V5yppNx-N8 [a 0?L )@_)=)T)+@ +` Gh7 [N)z[|)[[ a2 ^PP8U/RhBöZ’R x%WXP{bPgObofIio% 4X\#. 2Gp^\ _--015B1I /c_ x-RR7% _\max%x_\Qar Gm__ H!GX : {{i8l /*,tveDk*,B*` {K 3PE zSqS\WVSgS,z E/( Iippr*ryDrx htI3ttV O/6 1=E VOiVZVS\zW nj 5g00 [X tO L5YHJ`j+5YY5# Hs u(u`uH`u(0 92- H]W]TtWT nf: ID~IyIFW3 Vv+LVF+DV 6Sk n|oIKIo6 One0 :W| {{~EI4{{d Dj&uH2o R#4e SR3Xw!X RZRuGS.
NzTr ~/ M;` M7gL777g~Y yfjYIAt6
(th QI[3IhI[AC n8QiWR? po X forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.
UM( s7spNxDv d0~pH J uARh (7FW_ ?Z M^jj7? i[ gitull QCi3[TCTR3^)4 1oP BRR 8P1Y8*|_nL %@W JGem sns/BsqBt LqDkq? B^\PSucOp Z,:}@ _KS2K[KS;{ ||9p)|6|9.
